BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheppard-Olivares S, Bello NM, Wood E, Szivek A, Biller B, Hocker S, Wouda RM. Toceranib phosphate in the treatment of canine thyroid carcinoma: 42 cases (2009-2018). Vet Comp Oncol 2020;18:519-27. [PMID: 32012432 DOI: 10.1111/vco.12571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Scheemaeker S, Inglebert M, Daminet S, Dettwiler M, Letko A, Drögemüller C, Kessler M, Ducatelle R, Rottenberg S, Campos M. Organoids of patient-derived medullary thyroid carcinoma: The first milestone towards a new in vitro model in dogs. Vet Comp Oncol 2022. [PMID: 36583463 DOI: 10.1111/vco.12872] [Reference Citation Analysis]
2 Renzi A, Sabattini S, D'annunzio G, Zaccone R, Perfetti S, Okonji S, Marconato L. Multiorgan metastases with massive bone involvement of a medullary thyroid carcinoma in a dog. Veterinary Clinical Pathol 2022. [DOI: 10.1111/vcp.13182] [Reference Citation Analysis]
3 Berry A, Hayes A, Schiavo L, Dobson J. Multimodal Treatment of a Canine Lingual Melanoma Using a Combination of Immunotherapy and a Tyrosine Kinase Inhibitors. Veterinary Sciences 2022;9:54. [DOI: 10.3390/vetsci9020054] [Reference Citation Analysis]
4 Sheppard‐olivares S, Bello NM, Johannes CM, Hocker SE, Biller B, Husbands B, Snyder E, Mcmillan M, Mckee T, Wouda RM. Toceranib phosphate in the management of canine insulinoma: A retrospective multicentre study of 30 cases (2009–2019). Veterinary Record Open 2022;9. [DOI: 10.1002/vro2.27] [Reference Citation Analysis]
5 Frezoulis P, Harper A. The role of toceranib phosphate in dogs with non-mast cell neoplasia: A systematic review. Vet Comp Oncol 2022. [PMID: 34981886 DOI: 10.1111/vco.12799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ichimata M, Nishiyama S, Matsuyama F, Fukazawa E, Harada K, Katayama R, Toshima A, Kagawa Y, Yamagami T, Kobayashi T. Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate. J Vet Med Sci 2021;83:1554-8. [PMID: 34408099 DOI: 10.1292/jvms.21-0254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jegatheeson S, Zuber M, Woodward AP, Cannon CM. Response of canine thyroid carcinomas to radioiodine. Vet Comp Oncol 2021. [PMID: 34476889 DOI: 10.1111/vco.12770] [Reference Citation Analysis]
8 Choi S, Nam Y, Kim J, Park H, Song K, Seo KW. Retrospective evaluation of toceranib phosphate (Palladia) for treatment of different tumor types in 31 dogs. Korean J Vet Res 2021;61:e10. [DOI: 10.14405/kjvr.2021.61.e10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Coto GM, Musser ML, Tropf MA, Ward JL, Seo YJ, Mochel JP, Johannes CM. A Multi-Institutional Retrospective Analysis of Toceranib Phosphate for Presumed or Confirmed Canine Aortic Body Chemodectomas. Front Vet Sci 2021;8:635057. [PMID: 33614771 DOI: 10.3389/fvets.2021.635057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]